Published May 17, 2011
Volume 19, Number 5

  • Ross Stores, Inc., an an S&P 500, Fortune 500 and Nasdaq 100 company which is headquartered in Hacienda, is donating $100,000 to the American Red Cross to assist in disaster relief efforts from the recent tornadoes, floods and other severe weather events that have affected large regions of the South.  In addition, from May 3-17, all Ross stores offered customers and associates the ability to make donations to the American Red Cross 2011 Spring Storm Relief Fund.  Online donations to can also be made via a link located at www.rossstores.com.    

    “Our heartfelt sympathies go out to our associates and neighbors throughout the South who may have suffered losses from these disasters,” said Michael Balmuth, Ross vice chairman and CEO.
  • Ellie Mae, Inc., has successfully completed the initial public offering (IPO) of 7.5 million shares of common stock. The Hacienda-based provider of mortgage origination technology saw a closing price of $6.77 per share on April 15, the stock’s first day of trading, up 13 percent from the IPO price of $6.00. In the IPO, the company offered 5 million shares of stock, with existing shareholders adding an additional 2.5 million shares.
  • Roche Molecular Diagnostics has filed for FDA clearance for a new standardized and fully automated DNA-based test for the common sexually transmitted diseases chlamydia and gonorrhea (CT/NG). Roche was the first company to offer a Polymerase Chain Reaction-based CT/NG test, and the new offering builds on that legacy while introducing novel features that meet customer needs.    

    The test runs on the company’s cobas 4800 platform, which was recently introduced in the US. The cobas 4800 System is designed to deliver new standards in laboratory testing efficiency and medically relevant diagnostic information.    

    “We are pleased to submit for review this innovative test that will address a key medical need,” said Paul Brown, Ph.D., head of Roche Molecular Diagnostics. “With this test Roche will expand the menu on the recently approved cobas 4800 platform currently in use in the US for HPV testing and so continue to improve the workflow for laboratories.”

Also in this issue ...